Close

Bristol-Myers Squibb (BMY) Tops Q4 EPS by 6c; Issues Light FY15 Outlook

January 27, 2015 7:32 AM EST

Bristol-Myers Squibb (NYSE: BMY) reported Q4 EPS of $0.46, $0.06 better than the analyst estimate of $0.40. Revenue for the quarter came in at $4.26 billion versus the consensus estimate of $4.02 billion.

Bristol-Myers Squibb sees FY2015 EPS of $1.55-$1.70, versus the consensus of $1.71.

For earnings history and earnings-related data on Bristol-Myers Squibb (BMY) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings, Guidance, Hot Earnings, Hot Guidance, Hot List

Related Entities

Earnings